Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
X-ray Crystal Structures of the Influenza M2 Proton Channel Drug-Resistant V27A Mutant Bound to a Spiro-Adamantyl Amine Inhibitor Reveal the Mechanism of Adamantane Resistance.
Thomaston JL, Konstantinidi A, Liu L, Lambrinidis G, Tan J, Caffrey M, Wang J, Degrado WF, Kolocouris A. Thomaston JL, et al. Among authors: konstantinidi a. Biochemistry. 2020 Feb 4;59(4):627-634. doi: 10.1021/acs.biochem.9b00971. Epub 2020 Jan 13. Biochemistry. 2020. PMID: 31894969 Free PMC article.
Chemical Probes for Blocking of Influenza A M2 Wild-type and S31N Channels.
Tzitzoglaki C, McGuire K, Lagarias P, Konstantinidi A, Hoffmann A, Fokina NA, Ma C, Papanastasiou IP, Schreiner PR, Vázquez S, Schmidtke M, Wang J, Busath DD, Kolocouris A. Tzitzoglaki C, et al. Among authors: konstantinidi a. ACS Chem Biol. 2020 Sep 18;15(9):2331-2337. doi: 10.1021/acschembio.0c00553. Epub 2020 Aug 27. ACS Chem Biol. 2020. PMID: 32786258 Free PMC article.
Unraveling the Binding, Proton Blockage, and Inhibition of Influenza M2 WT and S31N by Rimantadine Variants.
Drakopoulos A, Tzitzoglaki C, McGuire K, Hoffmann A, Konstantinidi A, Kolokouris D, Ma C, Freudenberger K, Hutterer J, Gauglitz G, Wang J, Schmidtke M, Busath DD, Kolocouris A. Drakopoulos A, et al. Among authors: konstantinidi a. ACS Med Chem Lett. 2018 Jan 29;9(3):198-203. doi: 10.1021/acsmedchemlett.7b00458. eCollection 2018 Mar 8. ACS Med Chem Lett. 2018. PMID: 29541360 Free PMC article.
The boundary lipid around DMPC-spanning influenza A M2 transmembrane domain channels: Its structure and potential for drug accommodation.
Konstantinidi A, Chountoulesi M, Naziris N, Sartori B, Amenitsch H, Mali G, Čendak T, Plakantonaki M, Triantafyllakou I, Tselios T, Demetzos C, Busath DD, Mavromoustakos T, Kolocouris A. Konstantinidi A, et al. Biochim Biophys Acta Biomembr. 2020 Mar 1;1862(3):183156. doi: 10.1016/j.bbamem.2019.183156. Epub 2019 Dec 14. Biochim Biophys Acta Biomembr. 2020. PMID: 31846647 Free article.
Comparative Perturbation Effects Exerted by the Influenza A M2 WT Protein Inhibitors Amantadine and the Spiro[pyrrolidine-2,2'-adamantane] Variant AK13 to Membrane Bilayers Studied Using Biophysical Experiments and Molecular Dynamics Simulations.
Konstantinidi A, Naziris N, Chountoulesi M, Kiriakidi S, Sartori B, Kolokouris D, Amentisch H, Mali G, Ntountaniotis D, Demetzos C, Mavromoustakos T, Kolocouris A. Konstantinidi A, et al. J Phys Chem B. 2018 Nov 1;122(43):9877-9895. doi: 10.1021/acs.jpcb.8b07071. Epub 2018 Oct 18. J Phys Chem B. 2018. PMID: 30285441
Molecular investigation of artificial and natural sweeteners as potential anti-inflammatory agents.
Chontzopoulou E, Papaemmanouil CD, Chatziathanasiadou MV, Kolokouris D, Kiriakidi S, Konstantinidi A, Gerogianni I, Tselios T, Kostakis IK, Chrysina ED, Hadjipavlou-Litina D, Tzeli D, Tzakos AG, Mavromoustakos T. Chontzopoulou E, et al. Among authors: konstantinidi a. J Biomol Struct Dyn. 2022;40(23):12608-12620. doi: 10.1080/07391102.2021.1973565. Epub 2021 Sep 9. J Biomol Struct Dyn. 2022. PMID: 34499023
62 results